A study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of asymptomatic mild to moderate symptomatic cases.
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/07/026462
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 62
1. Patients of either sex aged between 18-65 years
2. Patients who have been tested positive with SARS-CoV2 virus
Asymptomatic Patients
or
Patients with mild symptoms
or
Patients with moderate symptoms with respiratory rate < 30 per minute and oxygen
saturation > 90%
3. Voluntariness to participate in the trial
USCDC classification mild to moderate, severe and critical stages of COVID-19
Stage Features
Asymptomatic No specific clinical symptoms of COVID-19 disease
Mild to Moderate Mild clinical symptoms up to mild pneumonia
Severe Dyspnea, hypoxia, or >50% lung involvement on imaging
Critical Respiratory failure, shock, or multiorgan system dysfunction
The subject must be excluded from participating in the trial if they fulfill anyone of the criteria as
mentioned below:
1. COVID-19 patients with symptoms classified as severe or critical.
2. Suspected COVID-19, not tested positive for COVID-19 by RT-PCR
3. Persons with severe primary respiratory disease or pneumonia
4. Pregnant and lactating women
5. Persons with serious diseases such as Cancer, Heart Disease, Stroke, Disabilities, Mental
illnesses, etc., and who are considered to be excluded from the study as evaluated by the
investigators
6. COVID-19 positive cases participating as subjects in the interventional arm of other
COVID-19 clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method